ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund-Growth
Equity
Sectoral-Pharma
₹-1.12% 1D
NAV on
AI Summary
Chart
Overview
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Summary
Ionic Wealth AI
Loading...
Fund Overview
Rating
5
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹6625 Cr
Created on
5 July 2018
Fund Ranking
#2
/ 17 in Sectoral-Pharma
Risk Level
Very High
Very High
Returns
Trailing Return
Rolling Return
6 Month
12.0%
1 Year
6.4%
3 Year (CAGR)
24.5%
All Time (CAGR)
20.1%
Category Return
6 Month
15.8%
1 Year
10.9%
3 Year (CAGR)
21.9%
All Time (CAGR)
-
Asset Allocation
Equity
96.0%
Other
4.0%
Top 5 Holdings
Top 5 Sectors
Aarti Drugs
1.06%
Astrazeneca Pharma India
0.82%
Aurobindo Pharma
1.17%
Cipla
6.67%
Dr. Reddy's Laboratories
8.22%
Fund Information
Expense Ratio
2.09%
Exit Load
Exit load of 1% if redeemed within 15 days.
Lock-In Period
No Lock-In
Managed By
Dharmesh Kakkad
May 2020 - Present
Sharmila D'Silva
July 2022 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
1.12
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
16.44
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
1.26
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.